Sana Biotechnology, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | -$0.29 | -$0.29 | -$0.29 |
Q2 2024 | 1 | -$0.26 | -$0.26 | -$0.26 |
Q3 2024 | 3 | -$0.26 | -$0.22 | -$0.24 |
Q1 2025 | 2 | -$0.24 | -$0.24 | -$0.24 |
Q2 2025 | 1 | -$0.24 | -$0.24 | -$0.24 |
Q3 2025 | 1 | -$0.23 | -$0.23 | -$0.23 |
Q4 2025 | 1 | -$0.26 | -$0.26 | -$0.26 |
Sana Biotechnology, Inc. Earnings Date And Information
Sana Biotechnology, Inc. last posted its earnings results on Friday, November 8th, 2024. The company reported $-0.25 earnings per share for the quarter, topping analysts' consensus estimates of $-0.27 by $0.02. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Sana Biotechnology, Inc. has generated $-1 earnings per share over the last year ($-1.46 diluted earnings per share) and currently has a price-to-earnings ratio of -2.01. Sana Biotechnology, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based on prior year's report dates.
Sana Biotechnology, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/08/2024 | Q3 2024 | -$0.27 | -$0.25 | 0.02 | $0 | $0 |
08/08/2024 | Q2 2024 | -$0.27 | -$0.21 | 0.06 | $0 | $0 |
05/08/2024 | Q1 2024 | -$0.30 | -$0.49 | -0.19 | $0 | |
12/30/2023 | Q4 2023 | -$0.45 | $0 | |||
11/08/2023 | Q3 2023 | -$0.42 | $0.01 | 0.43 | $0 | |
08/03/2023 | Q2 2023 | -$0.42 | -$0.59 | -0.17 | $0 | |
05/08/2023 | Q1 2023 | -$0.38 | -$0.42 | -0.04 | $0 | |
03/16/2023 | Q4 2022 | -$0.41 | -$0.41 | 0 | $0 | |
11/02/2022 | Q3 2022 | -$0.39 | -$0.44 | -0.05 | $0 | |
08/04/2022 | Q2 2022 | -$0.46 | -$0.38 | 0.08 | $0 | |
05/10/2022 | Q1 2022 | -$0.38 | -$0.17 | 0.21 | $0 | |
03/16/2022 | Q4 2021 | $0.36 | -$0.60 | -0.96 | $0 | |
11/08/2021 | Q3 2021 | -$0.29 | -$0.46 | -0.17 | $0 | |
08/04/2021 | Q2 2021 | -$0.37 | $0.10 | 0.47 | $0 | |
05/05/2021 | Q1 2021 | -$0.35 | -$1.52 | -1.17 | $0 | |
03/24/2021 | Q4 2020 | -$0.41 | -$0.65 | -0.24 | $161.53 M | |
09/30/2020 | Q3 2020 | -$0.39 | $0 | |||
06/30/2020 | Q2 2020 | -$0.67 | $0 | |||
03/31/2020 | Q1 2020 | -$0.25 | $0 | |||
12/31/2019 | Q4 2019 | -$0.33 | $0 |
Sana Biotechnology, Inc. Earnings: Frequently Asked Questions
-
When is Sana Biotechnology, Inc.'s earnings date?
Sana Biotechnology, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based off last year's report dates.
-
Did Sana Biotechnology, Inc. beat their earnings estimates last quarter?
In the previous quarter, Sana Biotechnology, Inc. (:SANA) reported $-0.25 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.27 by $0.02.
-
How can I listen to Sana Biotechnology, Inc.'s earnings conference call?
The conference call for Sana Biotechnology, Inc.'s latest earnings report can be listened to online.
-
How can I read Sana Biotechnology, Inc.'s conference call transcript?
The conference call transcript for Sana Biotechnology, Inc.'s latest earnings report can be read online.
-
How much profit does Sana Biotechnology, Inc. generate each year?
Sana Biotechnology, Inc. (:SANA) has a recorded net income of $0. Sana Biotechnology, Inc. has generated $-1.46 earnings per share over the last four quarters.
-
What is Sana Biotechnology, Inc.'s price-to-earnings ratio?
Sana Biotechnology, Inc. (:SANA) has a price-to-earnings ratio of -2.01 and price/earnings-to-growth ratio is 0.09.